We Give Shareholders a Voice
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Synthorx, Inc. (“Synthorx” or the “Company”) (NASDAQ: THOR) to Sanofi (NASDAQ: SNY). Under the terms of the transaction, Synthorx shareholders will receive $68 per share in cash.
The Synthorx merger investigation concerns whether the Board of Synthorx breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction and whether Sanofi is underpaying for Synthorx shares, thus unlawfully harming Synthorx shareholders.
To receive more information, please fill out the form.